Thermo Fisher to buy Swedish firm for $3.5b
Laboratory sciences supplier Thermo Fisher Scientific Inc. of Waltham said it has agreed to acquire Phadia, a Swedish company focused on allergy and autoimmunity diagnostics, for about $3.5 billion in cash.
"The acquisition of Phadia is a major step forward in our strategy to enhance Thermo Fisher's global presence in specialty diagnostics, one of our key growth platforms," Marc N. Casper, president and chief executive of Thermo Fisher, said in a statement.
Earlier this week, Thermo Fisher said it acquired Sterilin Ltd., a British company that provides single-use plastic products serving the microbiology, life sciences, and clinical markets.
And Thermo Fisher just closed on its $2.1 billion purchase of Dionex Corp., a California maker of chromatography equipment used in everything from drug manufacturing to testing for contaminants in drinking water.
The Phadia transaction is expected to be completed in the fourth quarter, said Thermo Fisher in a press release, which added that it is buying Phadia from Cinven, a European private equity firm.